Factors contributing to poor compliance with anti-TB treatment among tuberculosis patients

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 32, Issue 2, 2001, Pages 369-382

  Naing, Nyi Nyi ^a   D'Este, Catherine ^c   Isa, Abdul Rahman ^a   Salleh, Rosemi ^b   Bakar, Noraini ^b   Mahmod, Mohd Robi ^b  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

^b General Hospital Kota Bharu   (Malaysia)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; HUMAN; MALAYSIA; MIDDLE AGED; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; STATISTICAL MODEL; TUBERCULOSIS;

ADULT; AGED; ANTITUBERCULAR AGENTS; CROSS-SECTIONAL STUDIES; HUMANS; LOGISTIC MODELS; MALAYSIA; MIDDLE AGED; PATIENT COMPLIANCE; TUBERCULOSIS;

EID: 0035376575     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Abdullah S. National health morbidity survey: Communicable diseases. Ministry of Health Malaysia. 1996: 133-5.
2. Albert RK, Sbarbaro JA, Hudson LD, et al. High dose ethambutol: its role in intermittent chemotherapy, a six - year study. Am Rev Respir Dis 1976; 114: 699-704.
3. Anonymous. Annual Report. Kota Bharu General Hospital, Kelantan, Ministry of Health, Malaysia. 1998-1999.
4. Barnes PF, Barrows SA. Tuberculosis in the 1990's. Ann Intern Med 1993; 119: 400-10.
5. Bifani PJ, Plikaytis BB, Kapur V, et al. Origin and interstate spread of a New York City multidrug - resistant Mycobacterium tuberculosis lone family. JAMA 1996; 275: 452-7.
6. Brudney K, Dobkin J. A tale of two cities: tuberculosis control in Nicaragua and New York City. Sem Respir Infect 1991a; 6: 261-72.
7. Brudney K, Dobkin J. Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis 1991b; 144; 745-9.
8. Cantwell MF, Snider DE, Cauthen GM, Onorato IM. Epidemiology of tuberculosis in the United States, 1985 through 1992. JAMA 1994; 272: 535-9.
9. Chaulet P, Larbaoui D, Grosset J, et al. Intermittent chemotherapy with isoniazid and streptomycin in Algieers. Tubercle 1967; 48: 128-36.
10. Chaulk CP, Moore - Rice K, Rizzo R, Chaisson RE. Eleven years of community - based directly observed therapy for tuberculosis. JAMA 1995; 274: 945-51.
11. Chuah SY. Factors associated with poor patient compliance with antituberculosis therapy in Northwest Perak, Malaysia. Tubercle 1991; 72: 261-4.
12. Chowdhury AM, Alam A, Chowdhury SA, Ahmed J. Tuberculosis control in Bangladesh. Lancet 1992; 339: 1181-2.
13. Crespo R, Valdes L, Cayla JA. Difficulties in carrying out the treatment as seen by the tuberculous patient. Atencion Primaria 1992; 9: 260-2.
14. Cuneo WD, Snider DE. Enhancing patient compliance with tuberculosis therapy. Clin Chest Med 1989; 10: 375-80.
15. Drucker E, Alcabes P, Bosworth W, Sckell B. Childhood tuberculosis in the Bronx, New York. Lancet 1994; 343: 1482-5.
16. Dubler NN. Tuberculosis in the 1990s: ethical, legal and public policy issues in screening treatment, and the protection of those in congregate facilities. In: The tuberculosis revival - individual rights and societal obligation in a time of AIDS. New York: United Hopital Fund, 1992: 1-21.
17. Feinstein AR, Spagnualo M, Jonas S, et al. Prophylaxis of recurrent rheumatic fever. Therapeutic - continuous oral penicillin vs monthly injections. JAMA 1968; 206: 565-8.
18. Feintein AR, Wood HF, Epstein JA, et al. A controlled study of three methods of prophylaxis against Streptococcal infection in a population of rheumatic children. II. Results of the first three years of study, including methods for evaluating the maintenance of oral prophylaxis. N Engl J Med 1959; 260: 697-702.
19. Ferrer X, Krischbaum A, Toro J, et al. Compliance with tuberculosis treatment in adults in Santiago, Chile. Bolet Ofici Sanit Panam 1991; 111: 423-31.
20. Francis V, Korsch BM, Morris MJ. Gaps in doctor -patient communication, patient's response to medical advice. N Engl J Med 1969; 280: 535-40.
21. Frieden TR, Sterling T, Pablos Mendez A, et al. The emergence of drug - resistant tuberculosis in New York City. N Engl J Med 1993; 328: 521-6.
22. Fox W. Compliance of patients and physicians: a lesson from tuberculosis 2. Br Med J 1983; 287: 101-5.
23. Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore, Maryland: Johns Hopkins University Press, 1979.
24. Iseman MD, Cohn DL, Sbarbaro JA. Directly observed treatment of tuberculosis. We can't afford not to try it. N Engl J Med 1993; 328: 576-8.
25. Jonson DAW, Freeman H. Long - acting transquillizers. Practitioner 1972; 208: 395-400.
26. Kochi A. The global tuberculosis situation and new control strategies of the World Health Organization. Tubercle 1991; 72: 1-6.
27. Moulding T. New responsibilities for health departments and public health nurse in tuberculosis; keeping the outpatient on therapy. Am J Public Health 1966; 56; 416-27.
28. Murray CJL, Styblo K, Rouillon A. Tuberculosis in developing countries: burden, intervention and cost. Bull Tubercul Lung Dis 1990; 65: 1-24.
29. Narain JP, Raviglione MC, Kochi A. HIV - associated tuberculosis in developing countries: epidemiology and strategies for prevention. Tuberc Lung Dis 1992; 73: 311-21.
30. Nuwaha F. Factors influencing completion of treatment among tuberculosis patients in Mbarara district, Uganda . East African Med J 1997; 74: 690-3.
31. Pablos Mendez A, Knirsch CA, Barr RG, et al. Non adherence in Tuberculosis treatment :Predictors and consequence in New York City. Am J Med 1997; 102: 164-70.
32. Rosenstock IM. Patient compliance with health regimens. JAMA 1975; 234: 402-3.
33. Sloan JP, Sloan MC. An assessment of default and non - compliance in tuberculosis control in Pakistan. Trans R Soc Trop Med Hyg 1981; 75: 717-8.
34. Stephenson BJ, Rowe Bh, Haynes RB, et al. Is this patient taking the treatment as prescribed ? JAMA 1993; 269: 2779-81.
35. Stradling P, Poole GW. Twice weekly streptomycin plus isoniazid for tuberculosis. Tubercle 1970; 51: 44-7.
36. Strong EJ Intermittent chemotherapy in the northem territory of Australia. Med J Aust 1970; 2: 948-50.
37. Weis SE, Slocum PC, Biais FX, et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 1994; 330: 1179-84.
38. Wilkinson D. High - compliance tuberculosis treatment program in a rural community. Lancet 1994; 343: 647-8.
39. World Health Organization. Tuberculosis control and research strategies for the 1990s: memorandum from a WHO meeting, Bull WHO 1992; 70: 17-21.
40. World Health Organization. Tuberculosis Unit, Division of Communicable Disease. Guidelines for tuberculosis treatment in adults and children in National Tuberculosis Program. WHO/TUB/91: 161.